HIF-1α signaling activation by post-ischemia treatment with astragaloside iv attenuates myocardial ischemia-reperfusion injury

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Si, Jingwen ^a   Wang, Ning ^a   Wang, Huan ^b   Xie, Juan ^a   Yang, Jian ^a   Yi, Hui ^c   Shi, Zixuan ^a   Ma, Jing ^a   Wang, Wen ^a   Yang, Lifang ^a   Yu, Shiqiang ^a   Li, Junchang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Beijing Military Hospital PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; ASTRAGALOSIDE IV; CASPASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; PROTEIN BCL 2; 2-METHOXYESTRADIOL; ASTRAGALOSIDE A; ESTRADIOL; HERBACEOUS AGENT; SAPONIN; TRITERPENE;

ADULT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOWN REGULATION; DRUG STRUCTURE; ENZYME RELEASE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; HEART MUSCLE; HEART MUSCLE CELL; IN VITRO STUDY; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; DRUGS, CHINESE HERBAL; ESTRADIOL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IN VITRO TECHNIQUES; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SAPONINS; SIGNAL TRANSDUCTION; TRITERPENES; UP-REGULATION;

EID: 84907198617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107832     Document Type: Article

References (42)

1. Hausenloy DJ, Boston-Griffiths E, Yellon DM (2012) Cardioprotection during cardiac surgery. Cardiovasc Res 94(2): 253-265.
2. Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357(23): 2408
3. Schwartz Longacre L, Kloner RA, Arai AE, Baines CP, Bolli R, et al. (2011) New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation 124(10): 1172-1179.
4. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, et al. (2010) Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 87(3): 406-423.
5. Mewton N, Bochaton T, Ovize M (2013) Postconditioning the heart of S-Televation myocardial infarction patients. Circ J 77(5): 1123-1130.
6. Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, et al. (2009) Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 104(5): 469-483.
7. Hausenloy DJ, Baxter G, Bell R, Bøtker HE, Davidson SM, et al. (2010) Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol 105(6): 677-686.
8. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nature medicine 17(11): 1391-1401.
9. Ren S, Zhang H, Mu Y, Sun M, Liu P (2013) Pharmacological effects of Astragaloside IV: a literature review. J Tradit Chin Med 33(3): 413-416.
10. Li M, Qu YZ, Zhao ZW, Wu SX, Liu YY, et al. (2012) Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules. Neurochem Int 60(5): 458-465.
11. Gui D, Huang J, Liu W, Guo Y, Xiao W, et al. (2013) Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways. Apoptosis 18(4): 409-422.
12. Cheng MX, Chen ZZ, Cai YL, Liu CA, Tu B (2011) Astragaloside IV Protects Against Ischemia Reperfusion in a Murine Model of Orthotopic Liver Transplantation. Transplantat Proc 43(5): 1456-1461.
13. Gui D, Huang J, Guo Y, Chen J, Chen Y, et al. (2013) Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-kB-mediated inflammatory genes expression. Cytokine 61(3): 970-977.
14. Chen X, Peng LH, Li N, Li QM, Li P, et al. (2012) The healing and anti-scar effects of astragaloside IV on the wound repair in vitro and in vivo. J Ethnopharmacol 139(3): 721-727.
15. Li ZP, Cao Q (2002) Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats. Acta Pharmacol Sin 23(10): 898-904.
16. Zhang WD, Chen H, Zhang C, Liu RH, Li HL, et al. (2006) Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Med 72(1): 4-8.
17. Wu X, Cao Y, Nie J, Liu H, Lu S, et al. (2013) Genetic and Pharmacological Inhibition of Rheb1-mTORC1 Signaling Exerts Cardioprotection against Adverse Cardiac Remodeling in Mice. The American Journal of Pathology 182(6): 2005-2014.
18. Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148(3): 399-408
19. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, et al. (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342(9): 626-633.
20. Adluri RS, Thirunavukkarasu M, Dunna NR, Zhan L, Oriowo B, et al. (2011) Disruption of Hypoxia-Inducible Transcription Factor-Prolyl Hydroxylase Domain-1 (PHD-1-/-) Attenuates Ex Vivo Myocardial Ischemia/Reperfusion Injury Through Hypoxia-Inducible Factor-1 a Transcription Factor and Its Target Genes in Mice. Antioxid & redox signal 15(7): 1789-1797.
21. Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, et al. (2008) Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 a. Cardiovasc Res 77(3): 463-470.
22. Zhao HX, Wang XL, Wang YH, Wu Y, Li XY, et al. (2010) Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1 a. Basic Res Cardiol 105(1): 109-118.
23. Fang Li Q, Xu H, Sun Y, Hu R, Jiang H (2012) Induction of inducible nitric oxide synthase by isoflurane post-conditioning via hypoxia inducible factor-1aduring tolerance against ischemic neuronal injury. Brain Res 1451: 1-9.
24. Zhang L, Liu Q, Lu L, Zhao X, Gao X, et al. (2011) Astragaloside IV Stimulates Angiogenesis and Increases Hypoxia-Inducible Factor-1 Accumulation via Phosphatidylinositol 3-Kinase/Akt Pathway. J Pharmacol Exp Ther 338(2): 485-491.
25. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W (2005) hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 25: 297-310.
26. Cuong DV, Kim N, Youm JB, Joo H, Warda M, et al. (2006) Nitric oxidec-GMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+channels in rat hearts. Am J Physiol Heart Circ Physiol 290(5): H1808-17.
27. Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation. 118(19): 1915-1919.
28. Jones SP, Bolli R (2006) The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40(1): 16-23.
29. Brune B, Zhou J (2007) Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc Res 75(2): 275-282.
30. Yang Y, Duan W, Lin Y, Yi W, Liang Z, et al. (2013) SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med 65C: 667-679.
31. Smart N, Mojet MH, Latchman DS, Marber MS, Duchen MR, et al. (2006) IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. Cardiovascular Research 69(1): 164-177.
32. Punn A, Mockridge JW, Farooqui S, Marber MS, Heads RJ (2000) Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischemia mediates adaptive cytoprotection in cardiomyocytes. Biochem J. Pt 3: 891-9.
33. Esumi K, Nishida M, Shaw D, Smith TW, Marsh JD (1991) NADH measurements in adult rat myocytes during simulated ischemia. Am J Physiol. 260(6 Pt 2):H1743-52.
34. Yang Y, Duan W, Jin Z, Yi W, Yan J, et al. (2013) JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury. J Pineal Res 55(3): 275-286.
35. Zhao J, Yang P, Li F, Tao L, Ding H, et al. (2012) Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis. PLoS One 7(9): e44938.
36. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, et al. (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3(4): 363-375.
37. Salama SA, Kamel MW, Botting S, Salih SM, Borahay MA (2009) Catechol-omethyltransferase expression and 2-methoxyestradiol affect micro-toubule dynamics and modify steroid receptor signaling in leiomyoma cells. PLOS One 4(10):e7356.
38. Kim SR, Lee KS, Park HS, Park SJ, Min KH, et al. (2010) HIF-1alpha inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium. Eur J Immunol 40(10): 2858-69.
39. Lei J, Vodovotz Y, Tzeng E, Billiar TR (2013) Nitric Oxide, A Protective Molecule in the Cardiovascular System. Nitric Oxide 35C: 175-185.
40. Strijdom H, Friedrich SO, Hattingh S, Chamane N, Lochner A (2009) Hypoxiainduced regulation of nitric oxide synthase in cardiac endothelial cells and myocytes and the role of the PI3-K/PKB pathway. Mol Cell Biochem 321(1-2): 23-35.
41. Dijkers PF, O'Farrell PH (2009) Dissection of a hypoxia-induced, nitric oxidemediated signaling cascade. Mol Biol Cell 20(18): 4083-4090.
42. Belaidi E, Beguin PC, Levy P, Ribuot C, Godin-Ribuot D (2012) Delayed myocardial preconditioning induced by cobalt chloride in the rat: HIF-1α and iNOS involvement. Fundam Clin Pharmacol 26(4): 454-462.